The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs

被引:318
作者
Shugarts, Sarah [1 ]
Benet, Leslie Z. [1 ]
机构
[1] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
关键词
BDDCS; drug transporters; hepatic; intestinal; transporter/enzyme interplay; PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; INTESTINAL P-GLYCOPROTEIN; CANCER RESISTANCE PROTEIN; ORGANIC CATION TRANSPORTERS; ATP-BINDING CASSETTE; CONCENTRATIVE NUCLEOSIDE TRANSPORTER; MEMBRANE MONOAMINE TRANSPORTER; BLOOD-BRAIN-BARRIER; OATP-C SLC21A6;
D O I
10.1007/s11095-009-9924-0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug transporters are recognized as key players in the processes of drug absorption, distribution, metabolism, and elimination. The localization of uptake and efflux transporters in organs responsible for drug biotransformation and excretion gives transporter proteins a unique gatekeeper function in controlling drug access to metabolizing enzymes and excretory pathways. This review seeks to discuss the influence intestinal and hepatic drug transporters have on pharmacokinetic parameters, including bioavailability, exposure, clearance, volume of distribution, and half-life, for orally dosed drugs. This review also describes in detail the Biopharmaceutics Drug Disposition Classification System (BDDCS) and explains how many of the effects drug transporters exert on oral drug pharmacokinetic parameters can be predicted by this classification scheme.
引用
收藏
页码:2039 / 2054
页数:16
相关论文
共 170 条
[31]   The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-γ coactivator-1α, and suppressed by bile acids via a small heterodimer partner-dependent mechanism [J].
Eloranta, JJ ;
Jung, D ;
Kullak-Ublick, GA .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (01) :65-79
[32]   Interaction of organic cations with a newly identified plasma membrane monoamine transporter [J].
Engel, K ;
Wang, J .
MOLECULAR PHARMACOLOGY, 2005, 68 (05) :1397-1407
[33]   The role of permeability in drug ADME/PK, interactions and toxicity - Presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans [J].
Fagerholm, Urban .
PHARMACEUTICAL RESEARCH, 2008, 25 (03) :625-638
[34]   Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endotheliurn from gestational diabetes [J].
Farias, Marcelo ;
Martin, Rody San ;
Puebla, Carlos ;
Pearson, Jeremy D. ;
Casado, Javier F. ;
Pastor-Anglada, Marcal ;
Casanello, Paola ;
Sobrevia, Luis .
JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 208 (02) :451-460
[35]  
*FOOD DRUG ADM, GUID IND FOOD EFF BI
[36]  
Fromm MF, 2000, INT J CLIN PHARM TH, V38, P69
[37]   Identification of thyroid hormone transporters humans: Different molecules are involved in a tissue-specific manner [J].
Fujiwara, K ;
Adachi, H ;
Nishio, T ;
Unno, M ;
Tokui, T ;
Okabe, M ;
Onogawa, T ;
Suzuki, T ;
Asano, N ;
Tanemoto, M ;
Seki, M ;
Shiiba, K ;
Suzuki, M ;
Kondo, Y ;
Nunoki, K ;
Shimosegawa, T ;
Iinuma, K ;
Ito, S ;
Matsuno, S ;
Abe, T .
ENDOCRINOLOGY, 2001, 142 (05) :2005-2012
[38]   Localization of organic anion transporting polypeptides in the rat. and human ciliary body epithelium [J].
Gao, B ;
Huber, RD ;
Wenzel, A ;
Vavricka, SR ;
Ismair, MG ;
Remé, C ;
Meier, PJ .
EXPERIMENTAL EYE RESEARCH, 2005, 80 (01) :61-72
[39]   Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin [J].
Geick, A ;
Eichelbaum, M ;
Burk, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14581-14587
[40]   Intestinal drug transporter expression and the impact of grapefruit juice in humans [J].
Glaeser, H. ;
Bailey, D. G. ;
Dresser, G. K. ;
Gregor, J. C. ;
Schwarz, U. I. ;
McGrath, J. S. ;
Jolicoeur, E. ;
Lee, W. ;
Leake, B. F. ;
Tirona, R. G. ;
Kim, R. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) :362-370